HER2-Amplified Colorectal Cancer: Clinical Trial Data

Video

A focused discussion on HER2-amplified colorectal cancer and respective clinical trials that inform use of targeted agents in this setting.

Related Videos
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Katrina S. Pedersen, MD, MS, associate professor, John T. Milliken Department of Medicine, Division of Oncology, Medical Oncology program leader, cofounder, Young Onset Colorectal Cancer Program, Washington University School of Medicine in St. Louis, Siteman Cancer Center
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Video 15 - "Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment"
A panel of 4 experts on colorectal cancer
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Kathryn Beckermann, MD, PhD
Heinz-Josef Lenz, MD, FACP
Related Content
FDA

FDA to Hold End-of-Phase 2 Meeting for Botensilimab Plus Balstilimab in R/R mCRC

May 16th 2024
Article
Matthew Lunning, DO, FACP, associate professor, Division of Oncology & Hematology, associate vice chair, research, Department of Internal Medicine, assistant vice chancellor, clinical research, University of Nebraska Medical Center; Sarah Rutherford, MD, assistant professor, medicine, Division of Hematology/Oncology, Weill Cornell Medicine

Lunning and Rutherford Detail Considerations for BV-AVD Use in Older Patients With Hodgkin Lymphoma

April 18th 2024
Podcast
Benjamin A. Weinberg, MD

Advances in MRD Testing Help Guide Optimal Colorectal Cancer Therapy

May 10th 2024
Article
Carrie L. Kitko, MD, associate professor, pediatrics, medical director, the Pediatric Stem Cell Transplantation Program, the Ingram Professor of Pediatric Oncology, Monroe Carell Jr. Children’s Hospital at Vanderbilt; Sagar S. Patel, MD, director, Communications and Media Relationships, the Division of Hematology, the University of Utah Huntsman Cancer Institute

Kitko and Patel Emphasize the Importance of GVHD Research and Awareness

February 19th 2024
Podcast
FDA

FDA Approves Noninvasive Stool RNA Screening Test for CRC

May 7th 2024
Article
Dana Walker, MD, MSCE

EMA Validates MAA for Frontline Nivolumab/Ipilimumab for MSI-H/dMMR mCRC

May 6th 2024
Article